We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advised to Regulate Nanotechnology as New Products
FDA Advised to Regulate Nanotechnology as New Products
October 20, 2006
An FDA advisory committee is recommending that the agency require drug manufacturers to submit new drug applications (NDAs) for products containing nanotechnology, adding an influential voice to the growing debate over the FDA’s regulatory strategy for these products.